My research focuses on improvement of transfusion medicine practices, particularly as they apply to pediatric patients.
Publications
Monolobated megakaryocytes in Diamond–Blackfan anemia with RPL5 mutation at disease presentation mimicking myelodysplastic syndrome Pediatric Blood and Cancer DOI: 10.1002/pbc.30771 2024
Evaluation of Low-Cost Techniques to Detect Sickle Cell Disease and ¿-Thalassemia: An International Multi-Center Study SSRN 2024
Clinical and laboratory features associated with myeloperoxidase expression in pediatric B-lymphoblastic leukemia Cytometry Part B: Clinical Cytometry Eric McGinnis and David Yang and Nicholas Au and Douglas Morrison and Kate M. Chipperfield and Audi F. Setiadi and Lorraine Liu and Angela Tsang and Suzanne M. Vercauteren DOI: 10.1002/cyto.b.21966 10/2020
Feasibility of manual white blood cell counts as a predictor of neonatal sepsis in a low-resource setting Transactions of The Royal Society of Tropical Medicine and Hygiene Christian N Golding and Frederik Schaltz-Buchholzer and Lilica Sanca and Clara Clipet-Jensen and Christine S Benn and Nicholas Au and Kate Chipperfield and Tobias R Kollmann and Nelly A Amenyogbe DOI: 10.1093/trstmh/traa023 04/2020
Accuracy of Blood Transfusion Records in a Population-based Perinatal Data Registry Epidemiology Hutcheon, J.A. and Chapinal, N. and Skoll, M.A. and Au, N. and Lee, L. DOI: 10.1097/EDE.0000000000001183 2020
Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) Transfusion Turley, E. and McGowan, E.C. and Hyland, C.A. and Schoeman, E.M. and Flower, R.L. and Skoll, A. and Delisle, M.-F. and Nelson, T. and Clarke, G. and Au, N. DOI: 10.1111/trf.14944 2018
JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome Journal of Allergy and Clinical Immunology Del Bel, K.L. and Ragotte, R.J. and Saferali, A. and Lee, S. and Vercauteren, S.M. and Mostafavi, S.A. and Schreiber, R.A. and Prendiville, J.S. and Phang, M.S. and Halparin, J. and Au, N. and Dean, J.M. and Priatel, J.J. and Jewels, E. and Junker, A.K. and Rogers, P.C. and Seear, M. and McKinnon, M.L. and Turvey, S.E. DOI: 10.1016/j.jaci.2016.12.957 2017
Impact of preoperative laboratory investigation and blood cross-match on clinical management of pediatric neurosurgical patients Child's Nervous System Yang, M.M.H. and Singhal, A. and Au, N. and Hengel, A.R. DOI: 10.1007/s00381-015-2617-6 2015
Acute encephalopathy in a kidney transplant recipient following infusion of intravenous immunoglobulin Transplant International Wang, L. and Larkins, N. and Jung, B. and Au, N.H.C. and Mammen, C. DOI: 10.1111/tri.12384 2014
Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking Orphanet Journal of Rare Diseases Stockler, S. and Corvera, S. and Lambright, D. and Fogarty, K. and Nosova, E. and Leonard, D. and Steinfeld, R. and Ackerley, C. and Shyr, C. and Au, N. and Selby, K. and Van Allen, M. and Vallance, H. and Wevers, R. and Watkins, D. and Rosenblatt, D. and Ross, C.J. and Conibear, E. and Wasserman, W. and Van Karnebeek, C. DOI: 10.1186/s13023-014-0141-5 2014
Microdeletion of exon 3 in the HBA2 gene associated with mild a-thalassemia trait Hemoglobin Lambert, A. and Wong, A.Y.K. and Kominami, Y. and Smith, V.C. and Reddy, S. and Wadsworth, L.D. and Au, N.H.C. and MacGillivray, R.T.A. DOI: 10.3109/03630269.2013.763257 2013
Blueberry muffin rash and thrombocytopenia in a newborn with mucolipidosis type II (I-cell disease) masquerading as congenital infections Molecular Genetics and Metabolism Ting, J. and Hochwald, O. and Au, N. and Mercimek-Mahmutoglu, S. DOI: 10.1016/j.ymgme.2011.09.003 2011
Two new examples of Hb st. etienne [ß92(F8)His¿Gln] in association with venous thrombosis Hemoglobin Au, N.H.C. and Wong, A.Y.K. and Vickars, L. and MacGillivray, R.T.A. and Wadsworth, L.D. DOI: 10.1080/03630260902817206 2009
Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: A tissue microarray study of 284 cases and 18 markers Journal of Pathology Au, N.H.C. and Cheang, M. and Huntsman, D.G. and Yorida, E. and Coldman, A. and Elliott, W.M. and Bebb, G. and Flint, J. and English, J. and Gilks, C.B. and Grimes, H.L. DOI: 10.1002/path.1612 2004
Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells Cancer Research Kazanjian, A. and Wallis, D. and Au, N. and Nigam, R. and Venken, K.J.T. and Cagle, P.T. and Dickey, B.F. and Bellen, H.J. and Gilks, C.B. and Grimes, H.L. DOI: 10.1158/0008-5472.CAN-04-0633 2004
Detection and Genotyping of Varicella-Zoster Virus by TaqMan Allelic Discrimination Real-Time PCR Journal of Clinical Microbiology Campsall, P.A. and Au, N.H.C. and Prendiville, J.S. and Speert, D.P. and Tan, R. and Thomas, E.E. DOI: 10.1128/JCM.42.4.1409-1413.2004 2004
Research
Current Projects Neonatal alloimmune thrombocytopenia (NAIT) is a blood disease in newborns which develops when the pregnant mother produces antibodies that destroy the newborns' platelets. According to current guidelines, NAIT should be treated by transfusing a certain type of platelets (HPA-1a negative platelets). However, the availability of HPA-1a negative platelets is limited. I am currently conducting a study to determine if transfusion with random donor platelets is effective in treating NAIT.
Red blood cells are frequently transfused in acute care institutions for the management of anemia, however research has shown that approximately 30% of red cell transfusions may be inappropriate. Red blood cells are derived from voluntary human donors and represent a precious medical resource. Transfusions also carry risks to the recipient, some of which may lead to morbidity and even mortality. I am participating in a quality study to assess the appropriateness of medical red cell transfusions.
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.
The team, led by researchers from BC Children’s Hospital Research Institute and the University of British Columbia, is the first in Canada to combine these two techniques to identify and test a drug for a young patient's tumour in time for their treatment.
Congratulations to the investigators and their teams who were awarded funding through the Canadian Institutes of Health Research (CIHR) Fall 2024 Project Grant competition!
The findings from a BCCHR study played a part in integrating the multiple breath washout test into recent recommendations to screen children for pulmonary chronic graft-versus-host disease, a lung complication that can affect children who undergo a bone marrow transplant.
New research published in Nature Communications, identifies a key molecule that might be critical for the development of stem cell-based therapies for treating type 1 diabetes.
Dr. Kirk Schultz, an investigator at BC Children’s Hospital Research Institute, has been awarded the 2024 Geoffrey L. Hammond Lectureship in recognition of his leadership and significant contributions to improving the health and well-being of children in British Columbia and around the world.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.